ReviewChest computed tomography scans should be considered as a routine investigation in cystic fibrosis
Introduction
When a child with cystic fibrosis (CF) is born, the lungs have normal structure. Early in life, the lungs become colonised with micro-organisms such as Staphylococcus aureus, Haemophilus influenzae, and Pseudomonas aeruginosa.1, 2 Protective mechanisms within the lung counter with an inflammatory response aimed at eliminating the micro-organisms. Both the micro-organisms and the inflammatory response contribute to structural lung damage and impaired lung function.
An important structural change within the lungs is bronchiectasis – an irreversible and progressive condition that eventually leads to end-stage lung disease (Fig. 1). Ideally, it should be our aim from the time of diagnosis of CF to prevent the development of any irreversible structural damage, such as bronchiectasis, or at least to minimise the progress of the lung disease. The course of disease varies widely between CF patients and cannot be adequately predicted for the individual patient based on the genotype. Hence, therapy must partially be tailored to the individual patient's needs.
The desirability of therapy should be weighed against negative aspects associated with CF therapy, such as interference with regular life, toxicity, and costs. To tailor treatment, the physician needs information that gives a clear picture about the condition of the lungs and of the progression of structural abnormalities.
Pulmonary function tests (PFTs) have been considered the most important tool for monitoring lung function. PFTs, however, are only an indirect measure of lung structure and are insensitive to localised or early damage. Many CF centres therefore add chest radiographs, which monitor lung structure more directly. Unfortunately, chest radiographs are considered to be insensitive to early disease, the quality of the radiographs is variable, and correct interpretation of the nature of the structural abnormalities is difficult. A new technique, computed tomography (CT), emerged in the early 1990s to become the gold standard for diagnosing bronchiectasis.3, 4, 5 It was found to be superior to chest radiography to monitor lung structure in CF patients.6, 7, 8, 9, 10
Clearly, in addition to structural and functional information, other considerations exist for optimal treatment of CF-related lung disease. Sputum cultures, for example, will identify micro-organisms present in the lung. However, this article focuses on the possible role of CT in the monitoring and treatment of CF lung disease. It argues that the information obtained from PFTs is dissociated from that obtained from CT and that both PFTs and CT are therefore needed to adequately assess a patient's pulmonary condition.
Section snippets
Early infection and inflammation
The basic defect in the gene encoding CF transmembrane regulator (CFTR) results in abnormal secretions in the lung that can be detected in sputum and bronchoalveolar lavage (BAL) fluid.2, 11 These abnormalities lead to early and severe inflammation in CF related to bacterial or viral infections.11 As many as 38% of newly diagnosed CF infants have a lower respiratory tract (LRT) infection by the age of 3 months.11 Considerable inflammation was detected in infants with LRT infection. Inflammatory
Structural lung damage
Both chronic bacterial infection and the exaggerated immune response observed in CF are responsible for structural damage in the airways and parenchyma. As a result of the chronic airway inflammation, the sputum of CF patients contains large quantities of aggressive enzymes, such as free neutrophil elastase.14 The chronic airway inflammation leads to changes in the architecture of the lung. Interestingly, CF patients show extreme inhomogeneity of pathological changes within the lung. For
Lung function and structural lung damage
Traditionally, lung function has been considered the gold standard for monitoring disease progression in CF. As CF lung disease begins early in life, much work was undertaken to develop lung function tools that can be used routinely in infancy. Unfortunately, it is technically difficult and time consuming to perform infant pulmonary function tests (iPFTs) in children between 1 and 5 years of age.30 The consistent finding of such studies is decreased expiratory flows,31 which seem to persist.32
Imaging and structural lung disease
Traditionally, chest radiographs were used to evaluate structural lung abnormalities in CF. Some CF centres undertake chest radiographs for each pulmonary exacerbation; others perform a chest radiograph only as part of the annual check-up. Chest radiographs are quick, relatively inexpensive, and require low radiation exposure and thus can be repeated more frequently when needed. They can also be done in unsedated young children. However, chest radiographs as a tool for the assessment of the
Therapy and imaging
Various interventional studies have used CT-related parameters as end points. Most data are available on the effect of RhDNase, which plays an important role in the treatment of CF lung disease. RhDNase reduces the viscosity of the sputum in CF and thus is thought to improve mucociliary clearance.16, 29 RhDNase has been shown to improve mucociliary clearance and quality of life, and to reduce the loss of lung function, inflammation, and exacerbation rate.29, 35, 38 The effect of RhDNase occurs
Risk--benefit of routine HRCT scanning
Using CT in the follow-up of CF-related lung disease exposes patients to more radiation than only chest radiographs. This issue should neither be underestimated nor overestimated. With current CT technology, one CT examination of the lung exposes the patient to an amount of radiation comparable to 1 year of natural background radiation in a low-dose region or 5 transatlantic flights. Extra exposure to radiation increases one's natural life-long risk of cancer. In a computational model we showed
Summary
Chest CT is the gold standard for the diagnosis of bronchiectasis. Bronchiectasis in CF is irreversible and, in most patients, a progressive disease. Longitudinal studies show that PFTs are insensitive to the presence of bronchiectasis. The information obtained from PFTs is dissociated from that obtained from CT in 50% of patients. Hence structure does not predict function and vice versa. The monitoring of CF lung disease with PTFs and chest radiographs alone underestimates the severity of
References (45)
Bronchiectasis
Radiologic Clinics of North America
(1998)- et al.
An automated approach to quantitative air trapping measurements in mild cystic fibrosis
Chest
(2003) - et al.
Spirometer-triggered high-resolution computed tomography and pulmonary function measurements during an acute exacerbation in patients with cystic fibrosis
J Pediatr
(2001) - et al.
Structural airway abnormalities in infants and young children with cystic fibrosis
J Pediatr
(2004) - et al.
A pilot study of the safety and efficacy of tobramycin s olution for inhalation in patients with severe bronchiectasis
Chest
(2005) Assessment of the respiratory status of infants and toddlers with cystic ibrosis [editorial; comment]
J Pediatr
(1998)- et al.
A two-year randomized, placebo controlled trial of dornase alfa in young cystic fibrosis patients with mild lung function abnormalities
Journal of Pediatrics
(2001) - et al.
Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis [see comments]
J Pediatr
(1997) - et al.
Lower airway inflammation in infants and young children with cystic fibrosis
Am J Resp Crit Care Med
(1997) - et al.
Early airway infection, inflammation, and lung function in cystic fibrosis
Arch Dis Child
(2002)
high resolution CT and bronchography in the asssessment of bronchiectasis
Acta Radiologica
Comparison of thin section computed tomography with bronchography for identifying bronchiectatic segments in patients with chronic sputum production
Thorax
Cystic fibrosis: scoring system with thin-section CT
Radiology
Cystic fibrosis in children: HRCT findings and distribution of disease
J Thorac Imaging
Ultrafast computerized tomography of the chest in cystic fibrosis: a new scoring system
Pediatr Pulmonol
Cystic fibrosis: when should high-resolution computed tomography of the chest Be obtained?
Pediatrics
Chest radiology in cystic fibrosis: is scoring useful
Thorax
Lower airway inflammation in cystic fibrosis infants
Pediatr Pulmonol
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis
J Infect Dis
Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis
JAMA
Regional variability of lung inflammation in cystic fibrosis
Am J Respir Crit Care Med
Cartilaginous airway dimensions and airflow obstruction in human lungs
Am J Resp Crit Care Med
Cited by (56)
The Clinical Use of Lung MRI in Cystic Fibrosis: What, Now, How?
2021, ChestCitation Excerpt :The main hallmarks in CF are, however, bronchiectasis (ie, irreversible dilatation of the airway lumen), wall thickening (ie, enlargement of the bronchial wall thickness), mucus plugs (ie, secretion of viscosity), and consolidations (ie, exudate that replaces alveolar air).18 Nevertheless, there used to be a debate on whether high-resolution morphologic imaging should be used as a standard tool in CF.19,20 Opponents stated that chest radiography is widely available, inexpensive, and easy to do, and that reproducible scoring methods are available. In addition, there was a lack of evidence that imaging might affect standard management.
The impact of chest computed tomography and chest radiography on clinical management of cystic fibrosis lung disease
2020, Journal of Cystic FibrosisTechnological advances shed light on left ventricular cardiac disturbances in cystic fibrosis
2017, Journal of Cystic FibrosisChest imaging in cystic fibrosis studies: What counts, and can be counted?
2017, Journal of Cystic FibrosisCitation Excerpt :As described subsequently in this review, markers from CT imaging can convey severity related to mild and regional CF lung disease by quantifying degrees of bronchiectasis, air trapping, and other attributes related to structural lung damage. It has been shown that CT markers have higher sensitivity to detect pulmonary disease progression than FEV1%, an established outcome in CF [5–9]. More recently, magnetic resonance imaging (MRI) techniques have emerged to provide radiation-free markers that quantify structural and dynamic aspects of the CF lung [10].
CT Density Distribution Analysis in Patients with Cystic Fibrosis: Correlation with Pulmonary Function and Radiologic Scores
2015, Academic RadiologyCitation Excerpt :The significant correlations of the indices of skewness and kurtosis with both radiologic scores and lung function in this study demonstrate that the analysis of the lung density distribution in patients with CF contains both structurally and functionally relevant information. This approach holds promise for the automated analysis of large data sets because CT-derived parameters have been proposed as end points in several studies (12,16,17). In this study, we did not find significant changes in the indices of skewness and kurtosis of the lung density distribution with time, despite significant changes in both LFT parameters and visual scores.
Progression of structural lung disease on CT scans in children with cystic fibrosis related diabetes
2013, Journal of Cystic Fibrosis